| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 9 | 0 | 0 | 9 |
| Chain A, Beta-lactamase | 5 | 0 | 0 | 5 |
| Chain A, 2-oxoglutarate Oxygenase | 8 | 0 | 0 | 8 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| AR protein | 19 | 0 | 0 | 19 |
| apical membrane antigen 1, AMA1 | 3 | 0 | 0 | 3 |
| estrogen nuclear receptor alpha | 24 | 0 | 0 | 24 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 1 | 0 | 0 | 1 |
| DNA polymerase eta isoform 1 | 2 | 0 | 0 | 2 |
| DNA polymerase iota isoform a (long) | 8 | 0 | 0 | 8 |
| urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
| plasminogen precursor | 1 | 0 | 0 | 1 |
| urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
| DNA polymerase kappa isoform 1 | 6 | 0 | 0 | 6 |
| ATP-binding cassette sub-family C member 3 | 0 | 16 | 0 | 16 |
| Multidrug resistance-associated protein 4 | 0 | 16 | 0 | 16 |
| Bile salt export pump | 0 | 4 | 0 | 4 |
| Bile salt export pump | 0 | 22 | 0 | 22 |
| Beta-lactamase SHV-1 | 0 | 0 | 0 | 2 |
| Beta-lactamase SHV-1 | 0 | 0 | 0 | 2 |
| Cytochrome P450 2C9 | 0 | 7 | 0 | 7 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Kappa-type opioid receptor | 0 | 0 | 0 | 2 |
| Solute carrier family 15 member 1 | 0 | 4 | 0 | 4 |
| Solute carrier family 15 member 1 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2J2 | 0 | 6 | 0 | 6 |
| B2 metallo-beta-lactamase | 0 | 0 | 0 | 2 |
| Solute carrier family 15 member 2 | 0 | 3 | 0 | 3 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Solute carrier family 15 member 2 | 0 | 3 | 0 | 3 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Canalicular multispecific organic anion transporter 1 | 0 | 14 | 0 | 14 |
| Chain A, HADH2 protein | 6 | 0 | 0 | 6 |
| Chain B, HADH2 protein | 6 | 0 | 0 | 6 |
| Chain A, Cruzipain | 6 | 0 | 0 | 6 |
| interleukin 8 | 3 | 0 | 0 | 3 |
| phosphopantetheinyl transferase | 4 | 0 | 0 | 4 |
| GLS protein | 7 | 0 | 0 | 7 |
| glucocorticoid receptor [Homo sapiens] | 16 | 0 | 0 | 16 |
| farnesoid X nuclear receptor | 13 | 0 | 0 | 13 |
| peroxisome proliferator-activated receptor delta | 12 | 0 | 0 | 12 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 8 | 0 | 0 | 8 |
| tumor necrosis factor | 2 | 0 | 0 | 2 |
| vitamin D3 receptor isoform VDRA | 6 | 0 | 0 | 6 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 19 | 0 | 0 | 19 |
| peripheral myelin protein 22 | 2 | 0 | 0 | 2 |
| lamin isoform A-delta10 | 13 | 0 | 0 | 13 |
| Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
| Cytochrome P450 3A4 | 0 | 5 | 0 | 5 |
| Cytochrome P450 2D6 | 0 | 3 | 0 | 3 |
| Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
| Nuclear receptor ROR-gamma | 4 | 0 | 0 | 4 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 6 | 0 | 6 |
| Aurora kinase B | 0 | 1 | 0 | 1 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 3 | 0 | 3 |
| Chain A, Mutant Al2 6e7p9g | 0 | 0 | 1 | 1 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 2 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| acid sphingomyelinase | 1 | 0 | 0 | 1 |
| GLI family zinc finger 3 | 17 | 0 | 0 | 17 |
| retinoic acid nuclear receptor alpha variant 1 | 19 | 0 | 0 | 19 |
| Beta-lactamase | 0 | 1 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Metallo-beta-lactamase type 2 | 0 | 0 | 0 | 2 |
| Metallo-beta-lactamase VIM-11 | 0 | 0 | 0 | 2 |
| euchromatic histone-lysine N-methyltransferase 2 | 13 | 0 | 0 | 13 |
| Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Metallo-beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 1 | 0 | 2 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 4 | 0 | 0 | 4 |
| chromobox protein homolog 1 | 10 | 0 | 0 | 10 |
| thyroid hormone receptor beta isoform 2 | 11 | 0 | 0 | 11 |
| DNA polymerase beta | 2 | 0 | 0 | 2 |
| geminin | 15 | 0 | 0 | 15 |
| Carbonic anhydrase 1 | 0 | 6 | 0 | 7 |
| Carbonic anhydrase 2 | 0 | 6 | 0 | 7 |
| 60 kDa heat shock protein, mitochondrial | 0 | 3 | 0 | 3 |
| Beta-lactamase OXA-7 | 0 | 0 | 0 | 1 |
| Spike glycoprotein | 7 | 0 | 0 | 7 |
| 10 kDa heat shock protein, mitochondrial | 0 | 3 | 0 | 3 |
| Angiopoietin-1 receptor | 0 | 0 | 1 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Thiosulfate sulfurtransferase | 0 | 3 | 0 | 3 |
| Metallo-beta-lactamase VIM-13 | 0 | 1 | 0 | 3 |
| Efflux transporter | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase Toho-1 | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Class D beta-lactamase | 0 | 0 | 0 | 1 |
| 60 kDa chaperonin | 0 | 3 | 0 | 3 |
| Metallo-beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| 10 kDa chaperonin | 0 | 3 | 0 | 3 |
| Metallo-b-lactamase | 0 | 0 | 0 | 2 |
| Carbapenem-hydrolyzing beta-lactamase KPC | 0 | 0 | 0 | 2 |
| Histamine H3 receptor | 0 | 0 | 0 | 2 |
| Beta-lactamase class B VIM-2 | 0 | 0 | 0 | 2 |
| Beta-lactamase VIM-1 | 0 | 1 | 0 | 3 |
| ATP-dependent phosphofructokinase | 7 | 0 | 0 | 7 |
| ATAD5 protein, partial | 4 | 0 | 0 | 4 |
| USP1 protein, partial | 6 | 0 | 0 | 6 |
| nuclear receptor subfamily 1, group I, member 3 | 12 | 0 | 0 | 12 |
| retinoid X nuclear receptor alpha | 12 | 0 | 0 | 12 |
| 67.9K protein | 1 | 0 | 0 | 1 |
| thyroid hormone receptor beta isoform a | 6 | 0 | 0 | 6 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 4 | 0 | 0 | 4 |
| Nicotinate phosphoribosyltransferase | 0 | 2 | 0 | 2 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 7 | 0 | 0 | 7 |
| Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
| GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
| ras protein, partial | 0 | 0 | 1 | 1 |
| thioredoxin reductase | 8 | 0 | 0 | 8 |
| aldehyde dehydrogenase 1 family, member A1 | 13 | 0 | 0 | 13 |
| thyroid stimulating hormone receptor | 3 | 0 | 0 | 3 |
| hypothetical protein, conserved | 1 | 0 | 0 | 1 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 10 | 0 | 0 | 10 |
| EWS/FLI fusion protein | 6 | 0 | 0 | 6 |
| estrogen-related nuclear receptor alpha | 18 | 0 | 0 | 18 |
| cytochrome P450 2D6 | 10 | 0 | 0 | 10 |
| glucocerebrosidase | 3 | 0 | 0 | 3 |
| Rac1 protein | 0 | 0 | 1 | 1 |
| IDH1 | 4 | 0 | 0 | 4 |
| cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
| Bloom syndrome protein isoform 1 | 4 | 0 | 0 | 4 |
| muscarinic acetylcholine receptor M1 | 6 | 0 | 0 | 6 |
| lethal factor (plasmid) | 6 | 0 | 0 | 6 |
| Prostaglandin-H2 D-isomerase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 3 | 0 | 3 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
| Fatty acid-binding protein, liver | 0 | 2 | 0 | 2 |
| Integrin beta-3 | 0 | 1 | 0 | 1 |
| Myeloperoxidase | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
| Integrin alpha-IIb | 0 | 1 | 0 | 1 |
| Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
| Adenosine receptor A1 | 0 | 3 | 0 | 4 |
| Adenosine receptor A2a | 0 | 3 | 0 | 5 |
| Substance-P receptor | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 3 |
| Urotensin-2 receptor | 0 | 1 | 0 | 1 |
| 4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
| Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 7 | 4 | 0 | 11 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 6 | 1 | 7 |
| Sigma non-opioid intracellular receptor 1 | 0 | 0 | 1 | 1 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 1 | 0 | 0 | 1 |
| Microtubule-associated protein tau | 4 | 0 | 0 | 4 |
| caspase-1 isoform alpha precursor | 2 | 0 | 0 | 2 |
| Caspase-7 | 2 | 0 | 0 | 2 |
| Inositol monophosphatase 1 | 3 | 0 | 0 | 3 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 3 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 2 | 0 | 3 |
| Chain A, Glycogen Phosphorylase | 0 | 1 | 0 | 1 |
| Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
| Chain A, glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
| Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
| Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
| Chain A, Chitinase | 0 | 1 | 0 | 1 |
| RAR-related orphan receptor gamma | 12 | 0 | 0 | 12 |
| pregnane X nuclear receptor | 15 | 0 | 0 | 15 |
| thyroid stimulating hormone receptor | 7 | 0 | 0 | 7 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 10 | 0 | 0 | 10 |
| atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
| nuclear receptor ROR-gamma isoform 1 | 5 | 0 | 0 | 5 |
| Voltage-dependent calcium channel gamma-2 subunit | 6 | 0 | 0 | 6 |
| Potassium channel subfamily K member 2 | 0 | 1 | 2 | 3 |
| Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
| Renin | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 3 | 0 | 3 |
| Glycogen phosphorylase, liver form | 0 | 1 | 0 | 1 |
| Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
| Adenosine receptor A3 | 0 | 3 | 0 | 3 |
| Replicase polyprotein 1ab | 0 | 2 | 0 | 2 |
| Glutamate receptor 2 | 6 | 0 | 0 | 6 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 3 | 0 | 3 |
| Amine oxidase [flavin-containing] B | 0 | 2 | 0 | 2 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 2 | 0 | 2 |
| Adenosine receptor A3 | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 2 | 1 | 4 |
| Adenosine receptor A2b | 0 | 1 | 0 | 2 |
| Adenosine receptor A2b | 0 | 2 | 0 | 3 |
| Adenosine receptor A1 | 0 | 1 | 1 | 4 |
| Vasopressin V2 receptor | 0 | 0 | 0 | 1 |
| Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 2 | 0 | 2 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 1 | 0 | 1 |
| DNA-dependent protein kinase catalytic subunit | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 1 | 0 | 0 | 0 | 1 |
| Chitotriosidase-1 | 0 | 1 | 0 | 1 |
| Serine-protein kinase ATM | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase ATR | 0 | 1 | 0 | 1 |
| Adenosine receptor A2b | 0 | 1 | 0 | 2 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
| Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 1 | 2 | 3 |
| Endochitinase B1 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor | 0 | 0 | 0 | 1 |
| Phosphodiesterase | 0 | 1 | 0 | 1 |
| Guanine deaminase | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase VIM-19 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Albumin | 0 | 1 | 3 | 4 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 2 |
| Solute carrier family 22 member 7 | 0 | 1 | 0 | 1 |
| BlaVIM-1 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 11 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 7 | 0 | 1 | 0 | 1 |
| TDP1 protein | 13 | 0 | 0 | 13 |
| G | 7 | 0 | 0 | 7 |
| peroxisome proliferator activated receptor gamma | 10 | 0 | 0 | 10 |
| aryl hydrocarbon receptor | 11 | 0 | 0 | 11 |
| activating transcription factor 6 | 8 | 0 | 0 | 8 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 4 | 0 | 0 | 4 |
| heat shock protein beta-1 | 4 | 0 | 0 | 4 |
| streptokinase A precursor | 0 | 0 | 1 | 1 |
| Dihydroxyacetone phosphate acyltransferase | 0 | 0 | 0 | 1 |
| Interferon beta | 9 | 0 | 0 | 9 |
| HLA class I histocompatibility antigen, B alpha chain | 7 | 0 | 0 | 7 |
| 30S ribosomal protein S6 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S7 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L15 | 0 | 1 | 0 | 1 |
| Cellular tumor antigen p53 | 13 | 0 | 0 | 13 |
| 50S ribosomal protein L10 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L11 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L7/L12 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L19 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L1 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L20 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L27 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L28 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L29 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L31 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L31 type B | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L32 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L33 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L34 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L35 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L36 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S10 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S11 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S12 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S13 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S16 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S18 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S19 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S20 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S2 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S3 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S4 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S5 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S8 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S9 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L13 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L14 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L16 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L23 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S15 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L17 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L21 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L30 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L6 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S14 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S17 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S1 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L18 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L2 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L3 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L24 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L4 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L22 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L5 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S21 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L25 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L36 2 | 0 | 1 | 0 | 1 |
| Inositol hexakisphosphate kinase 1 | 7 | 0 | 0 | 7 |
| Methionine--tRNA ligase, mitochondrial | 0 | 0 | 1 | 1 |
| cytochrome P450 2C9, partial | 7 | 0 | 0 | 7 |
| Carbonic anhydrase 4 | 0 | 2 | 0 | 3 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 15 | 0 | 1 | 0 | 1 |
| endonuclease IV | 3 | 0 | 0 | 3 |
| chaperonin-containing TCP-1 beta subunit homolog | 1 | 0 | 0 | 1 |
| hypoxia-inducible factor 1 alpha subunit | 8 | 0 | 0 | 8 |
| Estrogen receptor 1 | 0 | 1 | 0 | 1 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 5 | 0 | 0 | 5 |
| PINK1 | 1 | 0 | 0 | 1 |
| estrogen receptor 2 (ER beta) | 8 | 0 | 0 | 8 |
| progesterone receptor | 12 | 0 | 0 | 12 |
| Parkin | 2 | 0 | 0 | 2 |
| bromodomain adjacent to zinc finger domain 2B | 3 | 0 | 0 | 3 |
| Histone H2A.x | 6 | 0 | 0 | 6 |
| lysosomal alpha-glucosidase preproprotein | 2 | 0 | 0 | 2 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 4 | 0 | 0 | 4 |
| estrogen receptor beta isoform 1 | 0 | 1 | 0 | 1 |
| importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
| mitogen-activated protein kinase 1 | 3 | 0 | 0 | 3 |
| flap endonuclease 1 | 2 | 0 | 0 | 2 |
| snurportin-1 | 1 | 0 | 0 | 1 |
| GTP-binding nuclear protein Ran isoform 1 | 1 | 0 | 0 | 1 |
| cytochrome P450 3A4 isoform 1 | 7 | 0 | 0 | 7 |
| M-phase phosphoprotein 8 | 3 | 0 | 0 | 3 |
| neuropeptide S receptor isoform A | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 7 | 3 | 0 | 10 |
| Aldo-keto reductase family 1 member B1 | 0 | 5 | 0 | 5 |
| Muscarinic acetylcholine receptor M4 | 0 | 4 | 0 | 4 |
| Muscarinic acetylcholine receptor M5 | 0 | 4 | 0 | 4 |
| Alpha-2A adrenergic receptor | 0 | 5 | 0 | 6 |
| Neuronal acetylcholine receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 4 | 0 | 4 |
| Neuronal acetylcholine receptor subunit beta-2 | 1 | 0 | 0 | 1 |
| D(2) dopamine receptor | 0 | 4 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 7 | 3 | 0 | 10 |
| Alpha-2B adrenergic receptor | 0 | 4 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit delta | 7 | 3 | 0 | 10 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 7 | 3 | 0 | 10 |
| Alpha-2C adrenergic receptor | 0 | 4 | 0 | 5 |
| 5-hydroxytryptamine receptor 1A | 0 | 7 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 7 | 3 | 0 | 10 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 7 | 3 | 0 | 10 |
| Muscarinic acetylcholine receptor M3 | 0 | 4 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 7 | 3 | 0 | 10 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 7 | 3 | 0 | 10 |
| Sodium-dependent noradrenaline transporter | 0 | 6 | 0 | 6 |
| Alpha-1D adrenergic receptor | 0 | 4 | 0 | 5 |
| Cruzipain | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 4 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 7 | 3 | 0 | 10 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 7 | 3 | 0 | 10 |
| 5-hydroxytryptamine receptor 1B | 0 | 7 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 7 | 3 | 0 | 10 |
| Sodium-dependent serotonin transporter | 0 | 6 | 0 | 6 |
| Histamine H1 receptor | 0 | 4 | 0 | 4 |
| Mu-type opioid receptor | 0 | 4 | 0 | 4 |
| D(3) dopamine receptor | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 2B | 0 | 4 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 7 | 3 | 0 | 10 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 7 | 3 | 0 | 10 |
| Sodium-dependent dopamine transporter | 0 | 6 | 0 | 6 |
| GABA theta subunit | 7 | 3 | 0 | 10 |
| Gamma-aminobutyric acid receptor subunit epsilon | 7 | 3 | 0 | 10 |
| Chain A, CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION | 0 | 0 | 1 | 1 |
| Chain B, CHIMERA OF IG GAMMA-1 CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION | 0 | 0 | 1 | 1 |
| Chain H, Fab M82G2, Heavy chain | 0 | 0 | 1 | 1 |
| Chain L, Fab M82G2, Light chain | 0 | 0 | 1 | 1 |
| Chain H, Fab M82g2, Heavy Chain | 0 | 0 | 1 | 1 |
| Chain L, Fab M82g2, Light Chain | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit delta | 0 | 3 | 0 | 3 |
| Amyloid-beta precursor protein | 0 | 3 | 0 | 3 |
| Fatty acid-binding protein, heart | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2C | 0 | 3 | 0 | 3 |
| Tryptophan 5-hydroxylase 1 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 3 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 3 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 3 | 1 | 4 |
| D | 0 | 1 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 2 | 1 | 3 |
| Alpha-2C adrenergic receptor | 0 | 2 | 1 | 3 |
| Alpha-2A adrenergic receptor | 0 | 2 | 1 | 3 |
| Liver carboxylesterase 1 | 0 | 1 | 0 | 2 |
| Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 3 | 1 | 4 |
| 5-hydroxytryptamine receptor 1D | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1F | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2B | 0 | 3 | 0 | 3 |
| 5-hydroxytryptamine receptor 6 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 3 | 1 | 4 |
| Sodium-dependent serotonin transporter | 0 | 4 | 0 | 5 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 3 | 1 | 4 |
| 5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 5B | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
| Lysosomal Pro-X carboxypeptidase | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 3 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 3 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 3 | 1 | 4 |
| D(2) dopamine receptor | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit epsilon | 0 | 3 | 0 | 3 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| Leukotriene B4 receptor 1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 3 | 1 | 4 |
| Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 3 | 0 | 3 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 3 | 0 | 3 |
| 5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
| Leukotriene B4 receptor 2 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit theta | 0 | 3 | 0 | 3 |
| Transporter | 0 | 3 | 0 | 3 |
| acetylcholinesterase | 6 | 0 | 0 | 6 |
| SMAD family member 2 | 4 | 0 | 0 | 4 |
| SMAD family member 3 | 4 | 0 | 0 | 4 |
| caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
| caspase-3 | 1 | 0 | 0 | 1 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
| survival motor neuron protein isoform d | 4 | 0 | 0 | 4 |
| replicative DNA helicase | 0 | 0 | 0 | 1 |
| recombinase A | 0 | 0 | 1 | 1 |
| UDP-glucuronosyltransferase 1A9 | 0 | 0 | 0 | 3 |
| UDP-glucuronosyltransferase 2B17 | 0 | 0 | 0 | 1 |
| UDP-glucuronosyltransferase 2B7 | 0 | 2 | 0 | 4 |
| UDP-glucuronosyltransferase 1-6 | 0 | 1 | 0 | 3 |
| UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 2 |
| UDP-glucuronosyltransferase 1A7 | 0 | 0 | 0 | 1 |
| Eyes absent homolog 2 | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 3 | 0 | 0 | 3 |
| Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 3 | 0 | 0 | 3 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Chain A, BCL-2-RELATED PROTEIN A1 | 0 | 0 | 1 | 1 |
| unnamed protein product | 0 | 1 | 0 | 1 |
| transcriptional regulator ERG isoform 3 | 2 | 0 | 0 | 2 |
| heat shock protein HSP 90-alpha isoform 2 | 0 | 0 | 0 | 2 |
| bcl-2-like protein 11 isoform 1 | 0 | 0 | 1 | 1 |
| Histone deacetylase 3 | 0 | 3 | 0 | 3 |
| Rap guanine nucleotide exchange factor 3 | 2 | 0 | 0 | 2 |
| Chymotrypsinogen A | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 1 | 0 | 1 |
| Heme oxygenase 1 | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
| ATP-dependent translocase ABCB1 | 0 | 4 | 0 | 5 |
| Lanosterol 14-alpha demethylase | 0 | 1 | 1 | 2 |
| Aromatase | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B2, mitochondrial | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
| Heme oxygenase 2 | 0 | 1 | 0 | 1 |
| Malate dehydrogenase, cytoplasmic | 0 | 1 | 0 | 1 |
| Histone deacetylase 4 | 0 | 3 | 0 | 3 |
| Cytochrome P450 144 | 0 | 0 | 1 | 1 |
| Steroid C26-monooxygenase | 0 | 0 | 1 | 1 |
| Steroid C26-monooxygenase | 0 | 0 | 1 | 1 |
| Mycocyclosin synthase | 0 | 0 | 1 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
| TAR DNA-binding protein 43 | 2 | 0 | 0 | 2 |
| Histone deacetylase 1 | 0 | 3 | 0 | 3 |
| Lanosterol 14-alpha demethylase | 0 | 1 | 1 | 2 |
| Sterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
| Sterol 14-alpha demethylase | 0 | 1 | 1 | 2 |
| Histone deacetylase 7 | 0 | 3 | 0 | 3 |
| Histone deacetylase 2 | 0 | 3 | 0 | 3 |
| Polyamine deacetylase HDAC10 | 0 | 3 | 0 | 3 |
| Histone deacetylase 11 | 0 | 3 | 0 | 3 |
| 14-alpha sterol demethylase | 0 | 0 | 1 | 1 |
| Histone deacetylase 8 | 0 | 3 | 0 | 3 |
| Histone deacetylase 6 | 0 | 3 | 0 | 3 |
| Histone deacetylase 9 | 0 | 3 | 0 | 3 |
| Histone deacetylase 5 | 0 | 3 | 0 | 3 |
| heat shock protein 90, putative | 0 | 0 | 0 | 2 |
| likely tRNA 2'-phosphotransferase | 0 | 1 | 0 | 1 |
| Voltage-dependent T-type calcium channel subunit alpha-1G | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
| Voltage-dependent T-type calcium channel subunit alpha-1H | 0 | 0 | 1 | 1 |
| Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 2 subunit alpha | 0 | 2 | 0 | 2 |
| Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
| Alpha-1B adrenergic receptor | 0 | 3 | 0 | 3 |
| Cannabinoid receptor 1 | 0 | 2 | 0 | 2 |
| D(1A) dopamine receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2C | 0 | 3 | 0 | 3 |
| Delta-type opioid receptor | 0 | 1 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 3 | 0 | 3 |
| Voltage-dependent L-type calcium channel subunit beta-1 | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel subunit alpha-2/delta-1 | 0 | 1 | 0 | 1 |
| Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 1 | 0 | 1 |
| Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
| Potassium channel subfamily K member 2 | 0 | 1 | 0 | 1 |
| ATPase family AAA domain-containing protein 5 | 6 | 0 | 0 | 6 |
| Ataxin-2 | 6 | 0 | 0 | 6 |
| Voltage-dependent T-type calcium channel subunit alpha-1I | 0 | 0 | 1 | 1 |
| Prostaglandin D2 receptor 2 | 0 | 1 | 0 | 1 |
| Luciferase | 4 | 0 | 0 | 4 |
| thyrotropin-releasing hormone receptor | 2 | 0 | 0 | 2 |
| Carbonic anhydrase 12 | 0 | 1 | 0 | 2 |
| Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 6 | 0 | 1 | 0 | 2 |
| Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 2 |
| Carbonic anhydrase 7 | 0 | 1 | 0 | 2 |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
| 6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
| Holo-[acyl-carrier-protein] synthase | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 1 |
| Sodium/bile acid cotransporter | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 9 | 0 | 1 | 0 | 2 |
| Multidrug and toxin extrusion protein 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 1 | 0 | 2 |
| G-protein coupled receptor 35 | 0 | 1 | 1 | 2 |
| CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 14 | 0 | 1 | 0 | 2 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 2 |
| Thymidine kinase | 0 | 1 | 0 | 1 |
| ClpP | 1 | 0 | 0 | 1 |
| Fumarate hydratase | 2 | 0 | 0 | 2 |
| NFKB1 protein, partial | 2 | 0 | 0 | 2 |
| polyprotein | 2 | 0 | 0 | 2 |
| arylsulfatase A | 5 | 0 | 0 | 5 |
| Solute carrier family 22 member 1 | 0 | 3 | 0 | 5 |
| POU domain, class 2, transcription factor 2 | 0 | 0 | 0 | 1 |
| Transitional endoplasmic reticulum ATPase | 0 | 1 | 0 | 1 |
| Purine nucleoside phosphorylase | 0 | 0 | 1 | 1 |
| Chain B, EUKARYOTIC TRANSLATION INITIATION FACTOR 4E | 0 | 0 | 1 | 1 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 7 | 0 | 0 | 7 |
| histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
| Smad3 | 1 | 0 | 0 | 1 |
| Type-1A angiotensin II receptor | 0 | 1 | 0 | 1 |
| Type-1B angiotensin II receptor | 0 | 2 | 0 | 2 |
| Type-2 angiotensin II receptor | 0 | 1 | 0 | 1 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 2 | 0 | 2 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
| Type-1 angiotensin II receptor | 0 | 1 | 0 | 1 |
| PPM1D protein | 2 | 0 | 0 | 2 |
| nonstructural protein 1 | 3 | 0 | 0 | 3 |
| nuclear receptor subfamily 1, group I, member 2 | 2 | 0 | 0 | 2 |
| muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
| Glucocorticoid receptor | 0 | 6 | 2 | 13 |
| Glycine receptor subunit alpha-1 | 0 | 6 | 0 | 6 |
| Androgen receptor | 0 | 3 | 0 | 3 |
| Glycine receptor subunit beta | 0 | 6 | 0 | 6 |
| Glycine receptor subunit alpha-2 | 0 | 6 | 0 | 6 |
| Glycine receptor subunit alpha-3 | 0 | 6 | 0 | 6 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
| Translocator protein | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A4 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 2B10 | 0 | 1 | 0 | 1 |
| cytochrome P450 2C19 precursor | 2 | 0 | 0 | 2 |
| D-amino-acid oxidase | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit rho-1 | 0 | 0 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit rho-2 | 0 | 0 | 1 | 1 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
| regulator of G-protein signaling 4 | 3 | 0 | 0 | 3 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Chain H, Igg2b-kappa 40-50 Fab (heavy Chain) | 0 | 1 | 0 | 1 |
| Chain L, Igg2b-kappa 40-50 Fab (light Chain) | 0 | 1 | 0 | 1 |
| Chain A, Na, K-ATPase alpha subunit | 0 | 0 | 1 | 1 |
| STAT3, partial | 0 | 1 | 0 | 1 |
| Kruppel-like factor 5 | 0 | 1 | 0 | 1 |
| NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
| peripheral myelin protein 22 isoform 1 | 2 | 0 | 0 | 2 |
| ras-related protein Rab-9A | 1 | 0 | 0 | 1 |
| signal transducer and activator of transcription 1-alpha/beta isoform alpha | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 2 |
| Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 2 | 0 | 3 |
| Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 2 | 0 | 3 |
| Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 1 | 0 | 2 |
| Sodium/potassium-transporting ATPase subunit beta-2 | 0 | 1 | 0 | 2 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 2 |
| Solute carrier organic anion transporter family member 1A2 | 0 | 0 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 2 | 0 | 3 |
| Sodium/potassium-transporting ATPase subunit beta-3 | 0 | 1 | 0 | 2 |
| Sodium/potassium-transporting ATPase subunit gamma | 0 | 1 | 0 | 2 |
| Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 1 | 0 | 2 |
| Sodium/potassium-transporting ATPase subunit beta-3 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
| 15-lipoxygenase, partial | 2 | 0 | 0 | 2 |
| alpha-galactosidase | 1 | 0 | 0 | 1 |
| cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 2 | 1 | 3 |
| Beta-1 adrenergic receptor | 0 | 2 | 1 | 3 |
| 5-hydroxytryptamine receptor 1A | 0 | 1 | 2 | 3 |
| Beta-2 adrenergic receptor | 0 | 0 | 0 | 1 |
| Beta-3 adrenergic receptor | 0 | 2 | 1 | 3 |
| Beta-1 adrenergic receptor | 0 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 0 | 0 | 1 |
| Alpha-1B adrenergic receptor | 0 | 0 | 0 | 1 |
| Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
| luciferase | 0 | 0 | 0 | 1 |
| Estrogen receptor | 0 | 2 | 0 | 2 |
| Progesterone receptor | 0 | 2 | 0 | 3 |
| Glucocorticoid receptor | 0 | 1 | 1 | 2 |
| Glucocorticoid receptor | 0 | 0 | 1 | 1 |
| Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
| Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
| Androgen receptor | 0 | 2 | 0 | 2 |
| Glutamine synthetase | 0 | 0 | 1 | 1 |
| Histamine H1 receptor | 0 | 0 | 1 | 1 |
| Nociceptin receptor | 0 | 0 | 1 | 1 |
| Estrogen receptor beta | 0 | 2 | 0 | 2 |
| pregnane X receptor | 4 | 0 | 0 | 4 |
| thioredoxin glutathione reductase | 2 | 0 | 0 | 2 |
| Chain A, Ferritin light chain | 1 | 0 | 0 | 1 |
| glp-1 receptor, partial | 2 | 0 | 0 | 2 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
| Guanine nucleotide-binding protein G | 1 | 0 | 0 | 1 |
| Pyridoxal kinase | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 2 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
| Histidine-rich protein PFHRP-II | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D26 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D3 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 1 | 0 | 2 | 0 | 3 |
| Cytochrome P450 2D4 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 2 | 0 | 2 |
| Chain A, 6,7-Dimethyl-8-ribityllumazine Synthase | 0 | 0 | 1 | 1 |
| Chain B, 6,7-Dimethyl-8-ribityllumazine Synthase | 0 | 0 | 1 | 1 |
| Chain A, Breast cancer type 1 susceptibility protein | 1 | 0 | 0 | 1 |
| Chain H, Immunoglobulin Igg1 Heavy chain | 0 | 0 | 1 | 1 |
| Chain L, Immunoglobulin Igg1 Lambda Light Chain | 0 | 0 | 1 | 1 |
| Chain A, DODECIN | 0 | 0 | 1 | 1 |
| Chain A, DODECIN | 0 | 0 | 1 | 1 |
| Chain C, DODECIN | 0 | 0 | 1 | 1 |
| Chain E, DODECIN | 0 | 0 | 1 | 1 |
| NPYLR7B | 0 | 0 | 1 | 1 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | 1 | 0 | 0 | 1 |
| Riboflavin-binding protein | 0 | 1 | 1 | 2 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 6 | 0 | 2 | 0 | 2 |
| GALC protein | 1 | 0 | 0 | 1 |
| Sodium- and chloride-dependent taurine transporter | 0 | 1 | 0 | 1 |
| Proton-coupled amino acid transporter 1 | 0 | 1 | 0 | 1 |
| Protein Rev | 0 | 0 | 1 | 1 |
| Cocaine esterase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2A6 | 0 | 1 | 0 | 1 |
| Tissue factor | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B7 | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
| NAD-dependent protein deacylase sirtuin-5, mitochondrial | 0 | 1 | 0 | 1 |
| Alpha-1D adrenergic receptor | 0 | 1 | 0 | 1 |
| D-alanyl-D-alanine dipeptidase | 0 | 1 | 0 | 1 |
| Hsf1 protein | 0 | 0 | 1 | 1 |
| Phosphodiesterase | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 2 | 0 | 2 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 2 | 0 | 2 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 2 | 0 | 2 |
| cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 1 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |